Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohortsPeter Thuss‐Patience, Peter Reichardt, Albrecht Kretzschmar et al.|British Journal of Cancer|2011Cited by 23
Docetaxel and capecitabine for advanced gastric cancer: Phase II study investigating dose dependent efficacy in two patient cohortsPeter Thuss‐Patience, Peter Reichardt, Albrecht Kretzschmar et al.|Journal of Clinical Oncology|2008Cited by 1
Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studiesCatherine Thiéblemont, Paolo Ghia, Vanessa Innao et al.|Blood|2025Cited by 0